NCT05264662View on ClinicalTrials.gov

Pertussis Vaccination Among HIV-infected and HIV-uninfected Pregnant Women

PHASE4Active, not recruitingINTERVENTIONAL
Enrollment

511

Participants

Timeline

Start Date

March 8, 2022

Primary Completion Date

May 31, 2025

Study Completion Date

June 30, 2025

Conditions
dTap Vaccine
Interventions
DRUG

Adacel (Tdap)

Administer Adacel to hiv infected and hiv uninfected pregnant mothers

Trial Locations (1)

2192

Chris Hani Baragwanath Academic Hospital, Johannesburg

Sponsors

Collaborators (1)

Sanofi
All Listed Sponsors
collaborator

Sanofi

INDUSTRY

lead

Farzanah Laher

OTHER